We are live on ! Find out more
AHPI

Allied Healthcare Products

Delisted

AHPI was delisted on the 2nd of February, 2023.

12 hedge funds and large institutions have $876K invested in Allied Healthcare Products in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

20% less funds holding

Funds holding: 1512 (-3)

25% less capital invested

Capital invested by funds: $1.16M → $876K (-$288K)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change

AHPI Hedge Fund Activity: Q2 2021 in Review

12 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q2 2021, worth a combined $876K — down 25% from $1.16M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of AHPI and 2 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $201K. The largest seller was Bank of America, cutting an estimated $151K.

  • 12 institutional investors held Allied Healthcare Products (AHPI) as of Q2 2021, down from 15 in Q1 2021.
  • Funds reported $876K of Allied Healthcare Products stock for Q2 2021, down 25% quarter-over-quarter.
  • 2 funds opened new Allied Healthcare Products positions in Q2 2021 and 5 closed out, a net change of -3 holders.
  • The largest Allied Healthcare Products buyer in Q2 2021 was Renaissance Technologies, an estimated $201K added.
  • The largest Allied Healthcare Products seller in Q2 2021 was Bank of America, an estimated $151K sold.

Based on aggregated 13F filings for Q2 2021.